文献速递乳腺病理细胞病理与分子病理

人工智能在乳腺病理学中的应用:概述与最新进展

Artificial intelligence in breast pathology: Overview and recent updates.
PubMed 文献 · Hum Pathol · 2025-05-27

本文综述了人工智能在乳腺病理学中的主要进展,涵盖诊断分类、组织学分级、淋巴结转移检测和生物标志物定量等应用,并讨论了预后、治疗反应和肿瘤微环境分析等新兴角色。尽管数据质量、泛化性和临床整合等障碍仍存,未来方向包括基础模型、多模态数据整合和可解释AI。

要点

  • AI在乳腺病理诊断分类、分级和淋巴结转移检测中展现潜力
  • AI可用于ER、PR、HER2、Ki-67等生物标志物定量
  • 临床转化仍面临数据质量、泛化性和监管等挑战

核心结论

  • AI有望通过解决工作负荷和观察者间变异等挑战来变革乳腺病理学并推进患者护理。

研究设计与样本

  • 本文为综述,探讨了AI在乳腺病理学中的主要进展和新兴角色。

主要发现

  • AI应用于诊断和分类、组织学分级、淋巴结转移检测以及生物标志物定量(ER、PR、HER2、Ki-67等)。
  • AI在预后、治疗反应、肿瘤微环境分析和新型生物标志物发现中呈现新兴作用。

临床怎么用

  • AI工具可辅助乳腺病理诊断、分级、淋巴结转移检测和生物标志物定量。
  • 临床整合需关注数据质量、泛化性、模型可解释性和监管挑战。

局限性

  • 数据质量、泛化性、模型可解释性、监管挑战和临床工作流程整合仍是障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breast cancer remains a major global health concern where timely and accurate pathologic diagnosis is critical for effective management. The traditional reliance on expert interpretation of histopathology is increasingly challenged by rising workloads, inter-observer variability, and the complexity of current precision pathology. The advent of digital pathology through whole slide imaging (WSI) has enabled the integration of artificial intelligence (AI) into breast pathology practice, offering promising solutions to these challenges. This review explores the major advancements of AI in breast pathology, including its applications in diagnosis and classification, histological grading, lymph node metastasis detection, and biomarker quantification (ER, PR, HER2, Ki-67, and others). We also discuss AI's emerging roles in prognosis, treatment response, tumor microenvironment analysis, and the discovery of novel biomarkers. Despite the significant progress, barriers such as data quality, generalizability, model interpretability, regulatory challenges, and integration into clinical workflows remain. Future directions emphasize the development of foundation models, multimodal data integration, explainable AI, real-world clinical validation, and decentralized learning approaches. With careful navigation of these challenges and continued interdisciplinary collaboration, AI is poised to transform breast pathology and advance patient care.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Datwani S, Khan H, Niazi MKK, et al. Artificial intelligence in breast pathology: Overview and recent updates. Hum Pathol. 2025. PMID: 40441444. doi:10.1016/j.humpath.2025.105819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。